| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/29/2002 | CN1351599A Indole-type derivatives as inhibitors of P38 kinase |
| 05/29/2002 | CN1351598A Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions |
| 05/29/2002 | CN1351592A Acyl derivatives which treat VL4-4 related disorders |
| 05/29/2002 | CN1351591A 抗炎吲哚衍生物 Indomethacin derivative |
| 05/29/2002 | CN1351589A Vitamin D analogues and their pharmaceutical use |
| 05/29/2002 | CN1351588A Inhibitors of LFA-l binding to ICAMs and uses thereof |
| 05/29/2002 | CN1351503A Vaccine against streptococcus pneumoniae |
| 05/29/2002 | CN1351501A Vaccine against antigens from bacteriae |
| 05/29/2002 | CN1351498A Pyrrolotriazines inhibitors of kinases |
| 05/29/2002 | CN1351496A Medicaments containing inhibitors of cell-volume regulated human kinase h-sgk |
| 05/29/2002 | CN1351491A Salts of cis-[4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl)cyclohexan-1-carboxylate] |
| 05/29/2002 | CN1351490A Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases |
| 05/29/2002 | CN1350850A Soft capsule of superfine compound pearl powder and its preparing process |
| 05/29/2002 | CN1350847A Indications of Fusaimi |
| 05/29/2002 | CN1085687C Polymeric matrices and their uses in pharmaceutial compositions |
| 05/29/2002 | CN1085672C Phospholipid derivatives of phosphono-carboxylic acids, prodn, and use as antiviral |
| 05/28/2002 | US6395897 Drugs for enzyme inhibitors anticoagulants and treatment of autoimmune disease |
| 05/28/2002 | US6395879 Monoclonal antibodies against Campylobacter jejuni and Campylobacter coli outer membrane antigens |
| 05/28/2002 | US6395788 Methods and compositions for treating or preventing sleep disturbances and associated illnesses using very low doses of cyclobenzaprine |
| 05/28/2002 | US6395767 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
| 05/28/2002 | US6395763 Antitumor, anticancer agents; immunosuppressant |
| 05/28/2002 | US6395754 Antiinflammatory agents, cardiovascular disorders, antipyretics |
| 05/28/2002 | US6395734 Anticancer agents |
| 05/28/2002 | US6395514 Polynucleotides encoding chemokineα-5 |
| 05/28/2002 | US6395497 Suppression of leukocyte transferring in humans; administer immunoglobulins to humans, detect bound receptor, evaluate immune response |
| 05/28/2002 | US6395272 Therapeutic compounds comprised of anti-Fc receptor antibodies |
| 05/28/2002 | CA2325014C 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5h-benzo[5,6]cyclohepta[1,2-b]pyridine oral compositions |
| 05/28/2002 | CA2192675C Methods for treating motor deficits |
| 05/28/2002 | CA2181377C Tetracyclic derivatives, process of preparation and use |
| 05/28/2002 | CA2121256C Secreted mac-2-binding glycoprotein |
| 05/28/2002 | CA2083274C The pharmacological use of certain cystine derivatives |
| 05/28/2002 | CA2032653C Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
| 05/23/2002 | WO2002040676A2 Mutant allergens |
| 05/23/2002 | WO2002040671A2 Immunoglobulin superfamily proteins |
| 05/23/2002 | WO2002040532A1 A new polypeptide-prostatic gland specific membrane antigen 9 and the polynucleotide encoding it |
| 05/23/2002 | WO2002040517A2 M. tuberculosis chaperonin 60.1 and uses thereof |
| 05/23/2002 | WO2002040486A2 METHODS OF TREATING p38 KINASE-ASSOCIATED CONDITIONS AND PYRROLOTRIAZINE COMPOUNDS USEFUL AS KINASE INHIBITORS |
| 05/23/2002 | WO2002040462A2 Cysteine protease inhibitors |
| 05/23/2002 | WO2002040461A2 Aminoalkoxybiphenyl carboxamides as histamine-3 receptor ligands and their therapeutic applications |
| 05/23/2002 | WO2002040453A1 Substituted 2-phenylaminoimidazoline phenyl ketone derivatives as ip antagonists |
| 05/23/2002 | WO2002040450A1 (dihydro)isoquinoline derivatives as phosphodiesterase inhibitors |
| 05/23/2002 | WO2002040044A2 Chemoattractant recruitment of dendritic cells for enhancement of immunization |
| 05/23/2002 | WO2002040041A2 Orally ingestible preparation of mistletoe lectins and method |
| 05/23/2002 | WO2002040038A2 M. tuberculosis chaperonin 10 and uses thereof |
| 05/23/2002 | WO2002040037A2 M. tuberculosis chaperonin 60.1 and uses thereof |
| 05/23/2002 | WO2002040026A1 A new use of a pyridazinone derivative |
| 05/23/2002 | WO2002040016A2 Association of calpain inhibitors and reactive oxygen species trapping agents |
| 05/23/2002 | WO2002040013A1 Composition for stimulating the immune defence and iron metabolism, containing propionyl l-carnitine and lactoferrin |
| 05/23/2002 | WO2002040004A1 Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |
| 05/23/2002 | WO2002039948A2 Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants |
| 05/23/2002 | WO2002039885A2 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 05/23/2002 | WO2002039834A1 Nutritional composition for an immune condition |
| 05/23/2002 | WO2002032451A8 Vaccine composition comprising an antigen and a peptide having adjuvant properties |
| 05/23/2002 | WO2002003911B1 Prevention and treatment of alzheimer's disease |
| 05/23/2002 | WO2001092253A3 Inhibitors of alpha l beta 2 mediated cell adhesion |
| 05/23/2002 | WO2001090182A3 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits |
| 05/23/2002 | WO2001087884A3 Polyketide derivatives |
| 05/23/2002 | WO2001085792A8 Mu-1, member of the cytokine receptor family |
| 05/23/2002 | WO2001085208A3 Molecular antigen arrays and vaccines |
| 05/23/2002 | WO2001083755A3 Human anti-cd40 antibodies and methods of making and using same |
| 05/23/2002 | WO2001083513A3 Antisense modulation of inhibitor of dna binding-1 expression |
| 05/23/2002 | WO2001082948A3 Uses of tgap7 for the modulation of leucocyte activation |
| 05/23/2002 | WO2001081340A3 Heterocycles that are inhibitors of impdh enzyme |
| 05/23/2002 | WO2001081316A3 Substituted phenyl farnesyltransferase inhibitors |
| 05/23/2002 | WO2001080887A3 Methods and chemokin compositions for inducing an immune response |
| 05/23/2002 | WO2001079444A3 Albumin fusion proteins |
| 05/23/2002 | WO2001079164A3 N-substituted dithiocarbamates for the treatment of biological disorders |
| 05/23/2002 | WO2001076637A3 Peptide conjugates for drug delivery |
| 05/23/2002 | WO2001072707A3 Carbamate caspase inhibitors and uses thereof |
| 05/23/2002 | WO2001070703A3 Substituted 1-(4-aminophenyl)imidazoles and their use as anti-inflammatory agents |
| 05/23/2002 | WO2001053506A3 Virus strains for the oncolytic treatment of cancer |
| 05/23/2002 | WO2001049651A3 Aminomethyl-phenyl-cyclohexanone derivatives |
| 05/23/2002 | WO2001044206A9 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 05/23/2002 | WO2001041760A9 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 05/23/2002 | WO2000063204A3 Substituted azoles |
| 05/23/2002 | US20020062031 Bicyclic signal transduction inhibitors, compositions containing them & uses thereof |
| 05/23/2002 | US20020062023 Palau'amine; treatment of tumors, fungal infections and immunosuppressive affections. |
| 05/23/2002 | US20020062009 Monoclonal antibodies with reduced immunogenicity |
| 05/23/2002 | US20020061923 Diacid isoindoleine amide derivative |
| 05/23/2002 | US20020061914 Benzothiazole, benzooxazole and benzoimidazole derivatives as sodium or calcium channel modulators |
| 05/23/2002 | US20020061911 Enantiomers of 6-amino EM-12 and method of use |
| 05/23/2002 | US20020061906 Aerosol compositions |
| 05/23/2002 | US20020061905 Ethers of 7-desmethylrapamycin |
| 05/23/2002 | US20020061904 Hydroxyesters of 7-desmethylrapamycin |
| 05/23/2002 | US20020061898 Inhibitors of nucleoside metabolism |
| 05/23/2002 | US20020061878 Diazacycloalkanedione derivatives |
| 05/23/2002 | US20020061865 Bicyclic heterocycles that inhibit cyclin-dependent kinase or tyrosine kinase enzymes, or both, for treatment of proliferative disorders |
| 05/23/2002 | US20020061853 Caspase inhibtors and uses thereof |
| 05/23/2002 | US20020061848 An specific polypeptides comprising a Chlamydia antigen and the use of such polypeptides for the serodiagnosis and treatement of Chlamydia infection |
| 05/23/2002 | US20020061846 Administering to a mammal Group B- beta hemolytic streptococci(GBS) toxin receptors or immunogenic fragments to induce an immune response to the GBS receptors for prventing pathoangiogenic conditions |
| 05/23/2002 | US20020061844 Administering to the patient for inhibiting Fc receptor binding of immunoglobulin a compound selected from aromatic, heteroaromatic, cyclic, bicyclic and an amino acid derivative or salt |
| 05/23/2002 | US20020061843 Use of mCRP for delivery of materials into cells |
| 05/23/2002 | US20020061841 Asthma/allergy therapy that targets T-lymphocytes and/or eosinophils |
| 05/23/2002 | US20020061834 Human G-protein Chemokine receptor (CCR5) HDGNR10 |
| 05/23/2002 | US20020061316 Immunotherapeutic stress protein-peptide complexes against cancer |
| 05/23/2002 | US20020061315 Delivering allergen directly into lymph node of individual |
| 05/23/2002 | US20020061310 Compositions and methods for dendritic cell-based immunotherapy |
| 05/23/2002 | US20020061293 Transduced human hematopoietic stem cells |
| 05/23/2002 | US20020061281 Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
| 05/23/2002 | DE10056400A1 Galenische Formulierung Drug formulation |